Skip to main content
. 2024 Apr 30;28(1):184–197. doi: 10.1080/19768354.2024.2345644

Figure 1.

Figure 1.

Downregulation of oncogenic miR-29 and -140-5p causes TRAIL-induced Drug-tolerant (TDT) state. (A) A schematic diagram showing the strategy to generate TRAIL-revertant from the resistant cells. (B) Gene Ontology terms associated genes differentially expressed in TRAIL-resistant cell (H460R) compared with sensitive cell. Left panel is a principal component analysis showing clustering between sensitive and resistant quadruplicate. (C) Heatmap showing upregulated miR-29 target genes in H460R cell. (D) Heatmap of miR-29 target genes upregulated in TRAIL-resistant cells. Kaplan-Meier curve depicting the survival probability in the patients with LUAD associated with (E) miR-29 or (F) miR-140 expression. (G) The restored expression of miR-29 a/c and -140-5p in H460R in response to drug holiday. (H) Cell survival rate using CellTiter-Glo assay. Error bars indicate mean ±SD (n = 4) and the p-values were calculated by one-way ANOVA test (**p < 0.01). (I) Chamber invasion assay of H460R cell reconstituted by miR-29 and/or -140-5p. Error bars show mean ±SD (n = 6) and the p-values were calculated by two-tailed student t-test (* p < 0.05, **p < 0.01).